These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Proteomic biomarkers in plasma that differentiate rapid and slow decline in lung function in adult cigarette smokers with chronic obstructive pulmonary disease (COPD). Rana GS; York TP; Edmiston JS; Zedler BK; Pounds JG; Adkins JN; Varnum SM; Smith RD; Liu Z; Li G; Webb BT; Murrelle EL; Flora JW Anal Bioanal Chem; 2010 Jul; 397(5):1809-19. PubMed ID: 20442989 [TBL] [Abstract][Full Text] [Related]
3. Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers. Shaker SB; von Wachenfeldt KA; Larsson S; Mile I; Persdotter S; Dahlbäck M; Broberg P; Stoel B; Bach KS; Hestad M; Fehniger TE; Dirksen A Clin Respir J; 2008 Jan; 2(1):17-25. PubMed ID: 20298300 [TBL] [Abstract][Full Text] [Related]
4. Correlation between serum biomarkers and BODE index in patients with stable COPD. Liu SF; Chin CH; Wang CC; Lin MC Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260 [TBL] [Abstract][Full Text] [Related]
5. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients. Zhang L; Cheng Z; Liu W; Wu K COPD; 2013 Aug; 10(4):459-65. PubMed ID: 23537276 [TBL] [Abstract][Full Text] [Related]
6. [Expression and significance of immunoglobulin free light chains in serum and lung tissues from patients with chronic obstructive pulmonary disease]. Zhang M; Tao HC; Li YQ; Pei HS; Zhu SY; Chen B; Zhou RJ; Zhang MW Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):945-9. PubMed ID: 24503428 [TBL] [Abstract][Full Text] [Related]
7. Down-Regulation of Soluble α-Klotho is Associated with Reduction in Serum Irisin Levels in Chronic Obstructive Pulmonary Disease. Kureya Y; Kanazawa H; Ijiri N; Tochino Y; Watanabe T; Asai K; Hirata K Lung; 2016 Jun; 194(3):345-51. PubMed ID: 27140192 [TBL] [Abstract][Full Text] [Related]
8. Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease. Pelegrino NR; Tanni SE; Amaral RA; Angeleli AY; Correa C; Godoy I Am J Med Sci; 2013 Jun; 345(6):440-5. PubMed ID: 22874622 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083 [TBL] [Abstract][Full Text] [Related]
10. Endogenous hydrogen sulfide in patients with COPD. Chen YH; Yao WZ; Geng B; Ding YL; Lu M; Zhao MW; Tang CS Chest; 2005 Nov; 128(5):3205-11. PubMed ID: 16304263 [TBL] [Abstract][Full Text] [Related]
11. Annexin A1 is elevated in patients with COPD and affects lung fibroblast function. Lai T; Li Y; Mai Z; Wen X; Lv Y; Xie Z; Lv Q; Chen M; Wu D; Wu B Int J Chron Obstruct Pulmon Dis; 2018; 13():473-486. PubMed ID: 29440885 [TBL] [Abstract][Full Text] [Related]
12. Pilot analysis of the plasma metabolite profiles associated with emphysematous Chronic Obstructive Pulmonary Disease phenotype. Paige M; Burdick MD; Kim S; Xu J; Lee JK; Shim YM Biochem Biophys Res Commun; 2011 Oct; 413(4):588-93. PubMed ID: 21925153 [TBL] [Abstract][Full Text] [Related]
13. Airway wall thickness in patients with COPD and healthy current smokers and healthy non-smokers: assessment with high resolution computed tomographic scanning. Deveci F; Murat A; Turgut T; Altuntaş E; Muz MH Respiration; 2004; 71(6):602-10. PubMed ID: 15627871 [TBL] [Abstract][Full Text] [Related]
14. Increased serum levels of HSP27 as a marker for incipient chronic obstructive pulmonary disease in young smokers. Jan Ankersmit H; Nickl S; Hoeltl E; Toepker M; Lambers C; Mitterbauer A; Kortuem B; Zimmermann M; Moser B; Bekos C; Steinlechner B; Hofbauer H; Klepetko W; Schenk P; Dome B Respiration; 2012; 83(5):391-9. PubMed ID: 22469636 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD. Winkler C; Atochina-Vasserman EN; Holz O; Beers MF; Erpenbeck VJ; Krug N; Roepcke S; Lauer G; Elmlinger M; Hohlfeld JM Respir Res; 2011 Mar; 12(1):29. PubMed ID: 21396106 [TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of hypoxia-inducible factor-1α in patients with chronic obstructive pulmonary disease and smokers with normal lung function]. Tao H; Luo W; Pei H; Zhu S; Zhang M; Chen B; He J; Zhang M; Zhou R Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):852-5. PubMed ID: 25108440 [TBL] [Abstract][Full Text] [Related]
17. Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking. Kobayashi H; Kanoh S; Motoyoshi K Biomarkers; 2008 Jun; 13(4):385-92. PubMed ID: 18595202 [TBL] [Abstract][Full Text] [Related]
18. Metabolomics-based search for lung cancer markers among patients with different smoking status. Klupczynska-Gabryszak A; Daskalaki E; Wheelock CE; Kasprzyk M; Dyszkiewicz W; Grabicki M; Brajer-Luftmann B; Pawlak M; Kokot ZJ; Matysiak J Sci Rep; 2024 Jul; 14(1):15444. PubMed ID: 38965272 [TBL] [Abstract][Full Text] [Related]
19. Concomitant elevations of MMP-9, NGAL, proMMP-9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary disease. Bchir S; Nasr HB; Bouchet S; Benzarti M; Garrouch A; Tabka Z; Susin S; Chahed K; Bauvois B J Cell Mol Med; 2017 Jul; 21(7):1280-1291. PubMed ID: 28004483 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the severity of small airways obstruction and alveolar destruction in chronic obstructive pulmonary disease. Kawamoto T; Kanazawa H; Tochino Y; Kawaguchi T Respir Med; 2018 Aug; 141():159-164. PubMed ID: 30053962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]